Antikor selected to present at OBN CEO & Investor Forum, London, 24th November 2015

Antikor is one of 12 pre-screened companies to be selected to present at OBN CEO & Investor Forum in London on 24th November 2015. 

The 5th Annual OBN CEO & Investor Forum is the must attend life sciences investment event that provides a platform for OBN’s R&D Member companies to showcase new therapeutic drugs, devices and diagnostics to potential investors. Presenters are drawn solely from OBN’s Membership of innovative emerging companies, and the meeting provides valuable networking (for investors, venture capital partners, corporate venturers, angels, R&D and Pharmaceutical companies).